Global Anti-Obesity Therapeutics Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global Anti-Obesity Therapeutics Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC0007036
  • Published Date :
    May 31, 2024
  • Number of Pages :
    350

Product Description

The Anti-Obesity Therapeutics market was valued at US$ xx in 2023. The market for Anti-Obesity Therapeutics is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Anti-Obesity Therapeutics industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Anti-Obesity Therapeutics by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Anti-Obesity Therapeutics market are discussed.

The market is segmented by types: 
    Centrally Acting Anti-obesity Drugs
    Peripherally Acting Anti-obesity Drugs

It can be also divided by applications:
    Hospital Use
    Clinic Use
    Household
    Other

And this report covers the historical situation, present status and the future prospects of the global Anti-Obesity Therapeutics market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
    Bristol-Myers Squibb
    Eisai Company
    FlaxoSithKline plc.
    Novo Nordisk
    Alizyme
    BoehringerIngelheim GmbH
    Pfizer
    Takeda Pharmaceutical
    Rhythm Pharmaceuticals
    Shionogi USA
    Vivus
    Zafgen
    Norgine Pharmaceuticals Ltd.

Report Includes:
- xx data tables and xx additional tables
- An overview of global Anti-Obesity Therapeutics market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Anti-Obesity Therapeutics market
- Profiles of major players in the industry, including     Bristol-Myers Squibb,     Eisai Company,     FlaxoSithKline plc.,     Novo Nordisk,     Alizyme.....

Research objectives
    To study and analyze the global Anti-Obesity Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031.
    To understand the structure of Anti-Obesity Therapeutics market by identifying its various subsegments.
    Focuses on the key global Anti-Obesity Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    To analyze the Anti-Obesity Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Anti-Obesity Therapeutics submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content

Table of Contents

Global Anti-Obesity Therapeutics Market Report 2024, Forecast to 2031

1 Scope of the Study
    1.1 Anti-Obesity Therapeutics Introduction
    1.2 Research Programs
    1.3 Analysis of Macroeconomic Indicators
    1.4 Years Considered
    1.5 Methodology
    1.6 Data Source
    1.7 Research Objectives

2 Anti-Obesity Therapeutics Industry Overview
    2.1 Global Anti-Obesity Therapeutics Market Size (Million USD) Comparison by Regions (2024-2031)
        2.1.1 Anti-Obesity Therapeutics Global Main Region Market Analysis
    2.2 Market Analysis by Type
        2.2.1 Centrally Acting Anti-obesity Drugs
        2.2.2 Peripherally Acting Anti-obesity Drugs
    2.3 Market Analysis by Application
        2.3.1 Hospital Use
        2.3.2 Clinic Use
        2.3.3 Household
        2.3.4 Other
    2.4 Global Anti-Obesity Therapeutics Revenue, Sales and Market Share by Manufacturer
        2.4.1 Global Anti-Obesity Therapeutics Sales and Market Share by Manufacturer (2019-2023)
        2.4.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Manufacturer (2019-2023)
        2.4.3 Global Anti-Obesity Therapeutics Industry Concentration Ratio (CR5 and HHI)
        2.4.4 Top 5 Anti-Obesity Therapeutics Manufacturer Market Share
        2.4.5 Top 10 Anti-Obesity Therapeutics Manufacturer Market Share
        2.4.6 Date of Key Manufacturers Enter into Anti-Obesity Therapeutics Market
        2.4.7 Key Manufacturers Anti-Obesity Therapeutics Product Offered
        2.4.8 Mergers & Acquisitions Planning
    2.5 Anti-Obesity Therapeutics Historical Development Overview
    2.6 Market Dynamics
        2.6.1 Market Opportunities
        2.6.2 Market Risk
        2.6.3 Market Driving Force
        2.6.4 Porter's Five Forces Analysis
    2.7 Coronavirus Disease 2019 (Covid-19): Anti-Obesity Therapeutics Industry Impact
        2.7.1 How the Covid-19 is Affecting the Anti-Obesity Therapeutics Industry
        2.7.2 Anti-Obesity Therapeutics Business Impact Assessment - Covid-19
        2.7.3 Market Trends and Anti-Obesity Therapeutics Potential Opportunities in the COVID-19 Landscape
        2.7.4 Measures / Proposal against Covid-19

3 Related Market Analysis
    3.1 Related Market Overview
    3.2 Macro Analysis of Upstream Markets
    3.3 Key Players in Related Markets
    3.4 Related Markets Trend Analysis

4 Global Anti-Obesity Therapeutics Market Size Categorized by Regions
    4.1 Global Anti-Obesity Therapeutics Revenue and Market Share by Regions
        4.1.1 Global Anti-Obesity Therapeutics Sales and Market Share by Regions (2019-2023)
        4.1.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Regions (2019-2023)
    4.2 Europe Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
    4.3 APAC Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
    4.4 North America Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
    4.5 South America Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
    4.6 Middle East & Africa Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)

5 Europe Anti-Obesity Therapeutics Market Size Categorized by Countries
    5.1 Europe Anti-Obesity Therapeutics Revenue and Market Share by Countries
        5.1.1 Europe Anti-Obesity Therapeutics Revenue by Countries (2019-2023)
        5.1.2 Germany Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        5.1.3 UK Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        5.1.4 France Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        5.1.5 Russia Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        5.1.6 Italy Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        5.1.7 Spain Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
    5.2 Europe Anti-Obesity Therapeutics Revenue (Value) by Manufacturers (2019-2023)
    5.3 Europe Anti-Obesity Therapeutics Revenue and Market Share by Type (2019-2023)
    5.4 Europe Anti-Obesity Therapeutics Revenue and Market Share by Application (2019-2023)

6 Asia-Pacific Anti-Obesity Therapeutics Market Size Categorized by Countries
    6.1 Asia-Pacific Anti-Obesity Therapeutics Revenue and Market Share by Countries
        6.1.1 Asia-Pacific Anti-Obesity Therapeutics Revenue by Countries (2019-2023)
        6.1.2 China Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        6.1.3 Japan Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        6.1.4 Korea Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        6.1.5 India Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        6.1.6 Southeast Asia Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        6.1.7 Australia Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
    6.2 Asia-Pacific Anti-Obesity Therapeutics Revenue (Value) by Players (2019-2023)
    6.3 Asia-Pacific Anti-Obesity Therapeutics Revenue and Market Share by Type (2019-2023)
    6.4 Asia-Pacific Anti-Obesity Therapeutics Revenue and Market Share by Application (2019-2023)

7 North America Anti-Obesity Therapeutics Market Size Categorized by Countries
    7.1 North America Anti-Obesity Therapeutics Revenue and Market Share by Countries
        7.1.1 North America Anti-Obesity Therapeutics Revenue by Countries (2019-2023)
        7.1.2 United States Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        7.1.3 Canada Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        7.1.4 Mexico Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
    7.2 North America Anti-Obesity Therapeutics Revenue (Value) by Players (2019-2023)
    7.3 North America Anti-Obesity Therapeutics Revenue and Market Share by Type (2019-2023)
    7.4 North America Anti-Obesity Therapeutics Revenue and Market Share by Application (2019-2023)

8 South America Anti-Obesity Therapeutics Market Size Categorized by Countries
    8.1 South America Anti-Obesity Therapeutics Revenue and Market Share by Countries
        8.1.1 South America Anti-Obesity Therapeutics Revenue by Countries (2019-2023)
        8.1.2 Brazil Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
    8.2 South America Anti-Obesity Therapeutics Revenue (Value) by Players (2019-2023)
    8.3 South America Anti-Obesity Therapeutics Revenue and Market Share by Type (2019-2023)
    8.4 South America Anti-Obesity Therapeutics Revenue and Market Share by Application (2019-2023)

9 Middle East and Africa Anti-Obesity Therapeutics Market Size Categorized by Countries
    9.1 Middle East and Africa Anti-Obesity Therapeutics Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Anti-Obesity Therapeutics Revenue by Countries (2019-2023)
        9.1.2 GCC Countries Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        9.1.3 Turkey Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        9.1.4 Egypt Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
        9.1.5 South Africa Anti-Obesity Therapeutics Revenue and Growth Rate (2019-2023)
    9.2 Middle East and Africa Anti-Obesity Therapeutics Revenue (Value) by Players (2019-2023)
    9.3 Middle East and Africa Anti-Obesity Therapeutics Revenue and Market Share by Type (2019-2023)
    9.4 Middle East and Africa Anti-Obesity Therapeutics Revenue and Market Share by Application (2019-2023)

10 Global Anti-Obesity Therapeutics Market Segment by Type
    10.1 Global Anti-Obesity Therapeutics Revenue and Market Share by Type (2019-2023)
    10.2 Global Anti-Obesity Therapeutics Market Forecast by Type (2024-2031)
    10.3 Centrally Acting Anti-obesity Drugs Revenue Growth Rate
    10.4 Peripherally Acting Anti-obesity Drugs Revenue Growth Rate

11 Global Anti-Obesity Therapeutics Market Segment by Application
    11.1 Global Anti-Obesity Therapeutics Revenue Market Share by Application (2019-2023)
    11.2 Global Anti-Obesity Therapeutics Market Forecast by Application (2024-2031)
    11.3 Hospital Use Revenue Growth Rate (2015-2025)
    11.4 Clinic Use Revenue Growth Rate (2015-2025)
    11.5 Household Revenue Growth Rate (2015-2025)
    11.6 Other Revenue Growth Rate (2015-2025)

12 Market Forecast for Anti-Obesity Therapeutics
    12.1 Global Anti-Obesity Therapeutics Market Size Forecast (2024-2031)
    12.2 Anti-Obesity Therapeutics Market Forecast by Regions (2024-2031)
    12.3 Europe Anti-Obesity Therapeutics Revenue Market Forecast (2024-2031)
    12.4 APAC Anti-Obesity Therapeutics Revenue Market Forecast (2024-2031)
    12.5 North America Anti-Obesity Therapeutics Revenue Market Forecast (2024-2031)
    12.6 South America Anti-Obesity Therapeutics Revenue Market Forecast (2024-2031)
    12.7 Middle East & Africa Anti-Obesity Therapeutics Revenue Market Forecast (2024-2031)

13 Analysis of Anti-Obesity Therapeutics Industry Key Vendors
    13.1 Bristol-Myers Squibb
        13.1.1 Company Details
        13.1.2 Product Information
        13.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.1.4 Main Business Overview
        13.1.5 Bristol-Myers Squibb News
    13.2 Eisai Company
        13.2.1 Company Details
        13.2.2 Product Information
        13.2.3 Eisai Company Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.2.4 Main Business Overview
        13.2.5 Eisai Company News
    13.3 FlaxoSithKline plc.
        13.3.1 Company Details
        13.3.2 Product Information
        13.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.3.4 Main Business Overview
        13.3.5 FlaxoSithKline plc. News
    13.4 Novo Nordisk
        13.4.1 Company Details
        13.4.2 Product Information
        13.4.3 Novo Nordisk Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.4.4 Main Business Overview
        13.4.5 Novo Nordisk News
    13.5 Alizyme
        13.5.1 Company Details
        13.5.2 Product Information
        13.5.3 Alizyme Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.5.4 Main Business Overview
        13.5.5 Alizyme News
    13.6 BoehringerIngelheim GmbH
        13.6.1 Company Details
        13.6.2 Product Information
        13.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.6.4 Main Business Overview
        13.6.5 BoehringerIngelheim GmbH News
    13.7 Pfizer
        13.7.1 Company Details
        13.7.2 Product Information
        13.7.3 Pfizer Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.7.4 Main Business Overview
        13.7.5 Pfizer News
    13.8 Takeda Pharmaceutical
        13.8.1 Company Details
        13.8.2 Product Information
        13.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.8.4 Main Business Overview
        13.8.5 Takeda Pharmaceutical News
    13.9 Rhythm Pharmaceuticals
        13.9.1 Company Details
        13.9.2 Product Information
        13.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.9.4 Main Business Overview
        13.9.5 Rhythm Pharmaceuticals News
    13.10 Shionogi USA
        13.10.1 Company Details
        13.10.2 Product Information
        13.10.3 Shionogi USA Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.10.4 Main Business Overview
        13.10.5 Shionogi USA News
    13.11 Vivus
        13.11.1 Company Details
        13.11.2 Product Information
        13.11.3 Vivus Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.11.4 Main Business Overview
        13.11.5 Vivus News
    13.12 Zafgen
        13.12.1 Company Details
        13.12.2 Product Information
        13.12.3 Zafgen Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.12.4 Main Business Overview
        13.12.5 Zafgen News
    13.13 Norgine Pharmaceuticals Ltd.
        13.13.1 Company Details
        13.13.2 Product Information
        13.13.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Revenue and Gross Margin (2019-2023)
        13.13.4 Main Business Overview
        13.13.5 Norgine Pharmaceuticals Ltd. News

14 Research Findings and Conclusion

15 Appendix

Search results for Technology and Media Industry